Methods and compositions to inhibit edema factor and adenylyl cyclase

Details for Australian Patent Application No. 2008302667 (hide)

Owner Board of Regents, The University of Texas System Mission Pharmacal Co.

Inventors Schein, Catherine H.; Walter, Mary A.; Peterson, Johnny W.; Chen, Deliang; Gilbertson, Scott R.; Gao, Jian; Estrella-Jimenez, Maria

Agent Pizzeys

Pub. Number AU-A-2008302667

PCT Pub. Number WO2009/038842

Priority 60/944,375 15.06.07 US; 61/035,269 10.03.08 US

Filing date 13 June 2008

Wipo publication date 26 March 2009

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/038842 Priority application(s): WO2009/038842

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302672-N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides

2008302644-Medicament admixing system